Treatment of drug-resistant tuberculosis with gamma delta T cells with a cure rate of up to 87.5
JAMA Neurol: Safety Study of Follow-up Antiplatelet Therapy in Patients with Cerebral Hemorrhage and Stroke
Dual antiplatelet therapy for mild stroke: will lower blood pressure be better
JAK inhibitors to treat chronic graft anti-host disease reached the clinical end of phase 3
FDA approves Airduo ® Digihaler ™ for asthma sufferers
Contact Us
Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
(We`ll never share your email address with a third-party.)
鲁ICP备16009155号-1 | Copyright@Qingdao ECHEMI Technology Co., Ltd.
Welcome to ECHEMI